Schizophrenia affects roughly 1 in 345 people worldwide, about 23 million total, but the burden falls unevenly. Men are diagnosed more often and at younger ages, certain racial groups receive the diagnosis at disproportionately higher rates in the U.S., and people living in cities face roughly double the risk compared to those in rural areas. Understanding who carries the greatest risk involves genetics, gender, geography, and social factors that intersect in complex ways.
Men Develop Symptoms Earlier
Men typically develop schizophrenia 3 to 4 years earlier than women. The peak age of onset for men falls in the early to mid-twenties, while women most often experience their first episode in the late twenties. This gap matters because earlier onset tends to mean more disruption to education, career development, and social relationships during a critical life stage.
Women also show a pattern men don’t: a second, smaller peak of onset after age 40, often around perimenopause. Estrogen appears to have a protective effect on the brain, and when levels drop sharply during menopause, vulnerability increases. Before age 40, schizophrenia is more common in men. After 40, the balance shifts, and prevalence becomes higher among women. This two-peak pattern means women can be caught off guard by a late-life diagnosis that neither they nor their families expected.
Racial Disparities in Diagnosis
In the United States, Black Americans are diagnosed with schizophrenia at three to five times the rate of white Americans. Hispanic Americans are diagnosed at roughly three times the rate. These are some of the starkest racial disparities in all of psychiatry, and they have persisted across decades of research.
The critical question is whether these numbers reflect a genuine difference in prevalence or a pattern of misdiagnosis. Evidence points strongly toward the latter. Studies that control for clinical characteristics still find Black Americans more than three times as likely to receive a schizophrenia diagnosis. Research on hospital admissions has shown that Black patients receive a schizophrenia diagnosis at significantly higher rates than white patients presenting with similar symptoms. Clinician bias, cultural differences in how distress is expressed, and limited access to comprehensive psychiatric evaluation all contribute. For people in these communities, the practical consequence is that symptoms of mood disorders or trauma responses may be mislabeled as schizophrenia, leading to treatment plans that don’t match the actual condition.
Genetics Play the Largest Single Role
The general population has a lifetime risk of developing schizophrenia just under 1%. Having a first-degree relative with the condition (a parent, sibling, or child) raises that to about 6.5%. For identical twins, when one twin has schizophrenia, the other develops it more than 40% of the time. Fraternal twins share roughly 10 to 19% concordance. These numbers make schizophrenia one of the most heritable psychiatric conditions.
But the identical twin figure also reveals something important: if genetics were the whole story, the concordance rate would be 100%. The fact that more than half of identical twins don’t share the diagnosis means environment, prenatal conditions, and life experiences account for a substantial portion of risk. No single gene causes schizophrenia. Instead, hundreds of small genetic variations each contribute a tiny amount, and their combined effect interacts with everything else a person encounters.
What Happens Before Birth Matters
Several prenatal infections significantly raise the odds of a child developing schizophrenia decades later. Rubella exposure during pregnancy is the most dramatic example: 20% of prenatally exposed children went on to develop schizophrenia in adulthood, representing a 10 to 20-fold increase in risk. Influenza during the first trimester is associated with a 7-fold increase, while the parasite that causes toxoplasmosis raises risk about 2.5-fold.
The common thread appears to be the mother’s immune response rather than the infections themselves. When the immune system activates strongly during pregnancy, it produces inflammatory signaling molecules that can cross the placenta and affect fetal brain development. Researchers have found that one of these molecules, a chemical messenger called interleukin-8, was nearly twice as high during the second trimester in mothers whose children later developed schizophrenia. One estimate suggests that as many as 14% of schizophrenia cases could have been prevented if influenza during early to mid-pregnancy had been avoided. This is one reason prenatal care and maternal vaccination matter beyond the immediate health of the mother.
Urban Living and Social Stress
Growing up in a densely populated urban environment roughly doubles the risk of developing schizophrenia compared to growing up in a rural area. A large Danish national study found the raw risk ratio was about 2.0 for the most urban versus most rural areas. When researchers accounted for individual-level factors like family history and socioeconomic background, the ratio dropped to about 1.3, suggesting that part of the urban effect comes from the types of stressors concentrated in cities rather than city living itself.
What drives this isn’t entirely clear, but candidates include social isolation despite physical crowding, higher exposure to discrimination, noise and pollution, childhood adversity, and reduced access to green space. Immigration also appears to be a risk factor, particularly for people who move to countries where they become part of a visible ethnic minority. The stress of navigating a new culture while facing social exclusion may interact with genetic vulnerability in ways that tip the balance.
Substance Use Compounds the Problem
Between 40 and 70% of people with schizophrenia will struggle with substance use at some point in their lives. Cannabis use during adolescence has received particular attention because heavy use in the teenage years, when the brain is still developing, appears to increase risk in people who already carry genetic vulnerability. Tobacco use is also extremely common, with smoking rates among people with schizophrenia far exceeding those in the general population.
Substance use doesn’t just raise the initial risk. It worsens outcomes for people already living with the condition, making symptoms harder to manage and treatment less effective. It also complicates the diagnostic picture, since substance-induced psychosis can look nearly identical to schizophrenia in its early stages.
The Life Expectancy Gap
People with schizophrenia die 15 to 20 years earlier than the general population. The leading cause isn’t suicide, though suicide rates are elevated. It’s cardiovascular disease. People with schizophrenia have higher rates of heart disease, diabetes, and metabolic problems, driven by a combination of medication side effects, reduced access to routine medical care, higher rates of smoking, and the difficulty of maintaining healthy habits while managing a severe psychiatric condition.
Unnatural causes of death, including suicide and accidents, account for less than 20% of deaths in this population. The mortality gap from these causes has stayed relatively stable over time. What has actually widened is the gap from natural causes, meaning people with schizophrenia are falling further behind the general population in benefiting from advances in physical healthcare. This makes schizophrenia not just a psychiatric condition but a significant medical one, where the greatest threat to life comes from preventable physical illness rather than the psychiatric symptoms themselves.